Dergiler / Acta Medica / 2022 / Cilt: 53 - Sayı: 3

Are COVID-19 Vaccine Preference and COVID-19 Risk Differ in Individuals Living with HIV from The Normal Population?

Sayfa
245–250
Yayın Tarihi
2022-11-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: In our study, no difference was found in the vaccination status, vaccine preference, vaccination doses and COVID-19 history between two groups.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Coronavirus disease 2019 (COVID-19) may have a severe course in high-risk patients and people living with Human immunodeficiency virus (HIV, PLWH)) are also in this risk group.
📊
Temel Bulgular & Veri:The aim of the study was to compare the history of COVID-19, vaccination status, vaccine doses, and vaccine preferences of PLWH with the normal population.
💡
Sonuç & Katkı:Conclusion: In our study, no difference was found in the vaccination status, vaccine preference, vaccination doses and COVID-19 history between two groups.
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: Coronavirus disease 2019 (COVID-19) may have a severe course in high-risk patients and people living with Human immunodeficiency virus (HIV, PLWH)) are also in this risk group. The aim of the study was to compare the history of COVID-19, vaccination status, vaccine doses, and vaccine preferences of PLWH with the normal population. Materials and Methods: This study was a retrospective cross-sectional survey study. The PLWH were study group and patients without chronic disease were selected as a control group. Results: A total of 326 patients, 163 HIV positive and 163 without chronic disease, were included in the study. Of the patients, 142 (88.1%) were male, and the mean age was 46.69 ± 13.72 years. The number of patients who were not vaccinated was 36 (11.1%). When unvaccinated PLWH were evaluated, it was observed that women were less vaccinated than male patients (p=0.01). In PLWH, 145 (89.0%) of patients were vaccinated with single dose, 129 (79.1%) of patients with double dose, and 123 (75.5%) of patients with full dose; in the control group, 145 (89.0%) of patients with single dose, 131 (80.9%) of patients with double dose and 126 (77.3%) of patients with full dose were vaccinated. There was no difference between the groups in the preference of inactivated and mRNA vaccines (p=1.0). Before vaccination, 42 (12.9%) patients were infected. Twenty (12.3%) of these patients were in PLWH group, while 22 (13.5%) patients were in the control group. There were 28 (9.8%) patients who had COVID-19 during or after vaccination, and 10 (6.9%) of them were in PLWH group; 18 (12.4%) of them were in the control group. Conclusion: In our study, no difference was found in the vaccination status, vaccine preference, vaccination doses and COVID-19 history between two groups.

🔖

Bu Makaleye Atıf Yap

BAŞTUĞ, A., AYAZ, Ç. M. (2022). Are COVID-19 Vaccine Preference and COVID-19 Risk Differ in Individuals Living with HIV from The Normal Population?. Acta Medica, Cilt: 53 - Sayı: 3, 245–250. https://ajindex.com/articles/655765

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Brown LB, Spinelli MA, Gandhi M. The interplay between HIV and COVID-19: summary of the data and responses to date. Curr Opin HIV AIDS. 2021;16(1):63-73
  2. Lesko CR, Bengtson AM. HIV and COVID-19: Intersecting Epidemics With Many Unknowns. Am J Epidemiol. 2021;190(1):10-6
  3. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62
  4. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25
  5. Virata MD, Shenoi SV, Ladines-Lim J, Villanueva MS, Barakat LA. Cumulative burden of non-communicable diseases predicts COVID hospitalization among people with HIV: A one-year retrospective cohort study. PLoS One. 2021;16(12):e0260251
  6. Yang Y, Iwasaki A. Impact of Chronic HIV Infection on SARSCoV- 2 Infection, COVID-19 Disease and Vaccines. Curr HIV/ AIDS Rep. 2021:1-12
  7. Mascolo S, Romanelli A, Carleo MA, Esposito V. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better. J Med Virol. 2020;92(10):1777-8
  8. World Health Organization. Accessed date: 05 Deecember 2021. Available from: https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/covid-19-vaccines/ advice
  9. Republic of Turkey Ministry of Health. Accessed date: 05 December 2021. Available from: https://covid19asi.saglik. gov.tr
  10. Centers for Disease Control and Prevention. Accessed date: 12 December 2021. Available from: https://clinicalinfo.hiv. gov/en/guidelines/covid-19-and-persons-hiv-interimguidance/ interim-guidance-covid-19-and-persons-hiv
  11. D’Souza G, Tong W, Gustafson D, Alcaide ML, Lahiri CD, Sharma A, et al. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study. J Acquir Immune Defic Syndr. 2022;89(1):1-8
  12. Castel AD, Wilbourn B, Magnus M, Greenberg AE. SARSCoV- 2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV. AIDS Rev. 2020;22(3):133-42
  13. Geretti AM, Stockdale AJ, Kelly SH, Cevik M, Collins S, Waters L, et al. Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observationa